# American Shared Hospital Services (AMS)

> Source: Nexqual · https://nexqual.com/AMS · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, American Shared Hospital Services (AMS), nexqual.com/AMS" · informational, not investment advice.

**Price:** USD 1.26 (+0.00% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 1.26 · day 1.26–1.35 · 52w 1.21–2.39 · market cap $8.4M · ASE

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $30.4M, net income -$1.8M (-5.8% margin), free cash flow $3.5M (SEC filings).
- Analysts: None (1 analysts), mean target USD 4 (range 4–4).
- Total return with dividends: 1Y -44.3% vs S&P 500 +14.0%; 5Y -56.9% vs S&P 500 +76.9%.
- Next earnings: 2026-11-12, EPS estimate USD 0.01, revenue estimate $8.5M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M | $30.4M |
| Gross profit | $6.7M | $8.4M | $9.3M | $9.2M | $5.1M | — |
| Operating income | $1.4M | $2.4M | $270K | -$2.8M | -$3.6M | -$3.6M |
| Net income | $194K | $1.3M | $610K | $2.2M | -$1.6M | -$1.8M |
| EPS (diluted) | $0.03 | $0.21 | $0.10 | $0.33 | -$0.23 | — |
| Free cash flow | $4.6M | $6.8M | -$555K | -$7.8M | -$4.5M | $3.5M |
| Gross margin | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% | — |
| Operating margin | 7.7% | 12.3% | 1.3% | -9.9% | -12.8% | -11.8% |
| Net margin | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% | -5.8% |
| Revenue growth | -1.2% | +12.0% | +8.0% | +32.9% | -0.9% | — |
| Cash + short-term investments | $8.1M | $12.3M | $13.7M | $11.0M | $3.5M | — |
| Total debt | $15.7M | $13.7M | $13.3M | $20.4M | $17.4M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/S 0.3x · EV/EBITDA 18.9x · EV/Sales 1.1x · P/FCF 2.4x · P/B 0.4x · FCF yield 42.19% · Earnings yield -21.17% · Net debt $25.9M · EV $34.3M
P/E at fiscal year-ends: Dec 2024 9.8x, Dec 2023 24.9x.

## Analysts
Consensus None, 1 analysts; mean target USD 4 (low 4, high 4).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -44.3% | -56.9% |
| S&P 500 (SPY) | +14.0% | +76.9% |
| Per year | -44.5% | -15.5% |
| Volatility (annualized) | 59.5% | 41.1% |
| Max drawdown | -45.4% (Feb 2026→Oct 2026) | -64.0% (Feb 2023→Oct 2026) |

## Peers (Medical Care Facilities)
INNV (InnovAge Holding Corp.) USD 9.55 +0.32% · USPH (U.S. Physical Therapy, Inc.) USD 88.53 -0.23% · NUTX (Nutex Health Inc.) USD 209.59 +1.70% · PNTG (The Pennant Group, Inc.) USD 41.88 -0.83% · AGL (agilon health, inc.) USD 89.71 -0.64% · CMPS (COMPASS Pathways Plc - American) USD 11.18 -3.87%

## More
Full page: https://nexqual.com/AMS · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Direct Patient Services | $4.9M | 57.9% | +39.6% |
| Medical Equipment Leasing | $3.5M | 42.1% | -0.7% |
| Total revenue | $8.4M | 100% | — |

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Patient Income | $4.9M | 57.9% | +39.6% |
| Direct Patient Services | $4.9M | 57.9% | +39.6% |
| Rental Income From Medical Services | $3.5M | 42.1% | -0.7% |
| Medical Equipment Leasing | $3.5M | 42.1% | -0.7% |
| Pbrt Services | $2.3M | 27.8% | +22.1% |
| Total revenue | $8.4M | 100% | — |
The lines above cover 227.8% of total revenue.

## Customer concentration

Period ended 2025-12-31: 31%, 26% of revenue from unnamed direct customers (10-K, filed 2026-03-31).

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.01 | $0.03 | -66.7% | $8.5M | 1 |
| Next quarter (ends 2026-12-31) | $0.01 | $0.03 | -66.7% | $8.6M | 1 |
| Current fiscal year (ends 2026-12-31) | $-0.14 | $-0.05 | +180.0% | $32.7M | 1 |
| Next fiscal year (ends 2027-12-31) | — | — | — | $0 | — |